Refine
Year of publication
Document Type
- Article (44)
- Doctoral Thesis (6)
Language
- English (50) (remove)
Has Fulltext
- yes (50)
Is part of the Bibliography
- no (50)
Keywords
- - (33)
- Depression (6)
- Alexithymia (4)
- Childhood trauma (3)
- Stereotypes (3)
- obesity (3)
- Alzheimer’s disease (2)
- Brain-derived neurotrophic factor (2)
- Childhood abuse (2)
- Cortical thickness (2)
- Cortisol (2)
- Epidemiologie (2)
- FGF21 (2)
- Individualization (2)
- Obesity (2)
- PTSD (2)
- Posttraumatic stress disorder (2)
- Psychiatrie (2)
- Resilience (2)
- Self-stigma (2)
- Statistik (2)
- Substance use disorders (2)
- Vitamin D (2)
- depression (2)
- high-fat diet (2)
- immune system (2)
- machine learning (2)
- magnetic resonance imaging (2)
- mental health (2)
- microbiome (2)
- non-alcoholic fatty liver disease (2)
- Adverse consequences (1)
- Alcohol dependence (1)
- Alzheimer's disease (1)
- Anxiety (1)
- Attitudes (1)
- BISCWIT (1)
- Borderline personality disorder (1)
- COVID-19 (1)
- Centrality (1)
- Children (1)
- Clinimetrics (1)
- Cognitive Control (1)
- Comorbidity (1)
- Connectivity (1)
- Correlation networks (1)
- Cortex (1)
- Depressive symptoms (1)
- Disease management (1)
- Dissociation (1)
- ECG (1)
- Effectiveness of telemedicine treatment (1)
- Efficacy (1)
- Epigenetik (1)
- Familial transmission pathways (1)
- FreeSurfer (1)
- General Population (1)
- General population (1)
- Genetik (1)
- Germany (1)
- Glucocorticoid receptor (1)
- Handlungsüberwachung (1)
- Health behavior (1)
- Helplessness (1)
- Hippocampus (1)
- Hirnrinde (1)
- Inhibition (1)
- Internet (1)
- Kinder (1)
- Kognition (1)
- Kognitive Kontrolle (1)
- Mediation analysis (1)
- Mental Pain Questionnaire (1)
- Mental pain (1)
- Metabolomics (1)
- Monitoring (1)
- Mother-child disagreement (1)
- Myocardial infarction (1)
- NMR metabolomics (1)
- NR3C1 (1)
- PHQ-9 (1)
- Parenting (1)
- Pathological gambling (1)
- Patient-reported outcomes (1)
- Performance Monitoring (1)
- Psychopathologie (1)
- Psychopathology (1)
- RMSSD (1)
- Recurrent depression (1)
- SHIP (1)
- TNFα (1)
- TREML2 (1)
- Telemedicine (1)
- Telephone-based therapy (1)
- Time trend study (1)
- Tourette Syndrom (1)
- Tourette Syndrome (1)
- Tourette-Syndrom (1)
- Trauma (1)
- Treatment utilization (1)
- Urine diagnostics (1)
- Verbal memory (1)
- abuse (1)
- adolescents (1)
- affective disorders (1)
- albuminuria (1)
- alpha diversity (1)
- apolipoprotein E (1)
- attentive immobility (freezing) (1)
- bacterial community (1)
- behavioral characteristics (1)
- behaviour (1)
- benzoate metabolism (1)
- biomarker (1)
- bipolar disorder (1)
- body mass index (1)
- brain atrophy (1)
- cardiovascular diseas (1)
- caregiver (1)
- causal beliefs (1)
- causality (1)
- childhood maltreatment (1)
- children (1)
- chronic pain (1)
- chronotypes (1)
- cognitive behavioral therapy (1)
- complex problem solving (CPS) (1)
- computer-based testing (1)
- control diet (1)
- coping skills (1)
- cross-cultural psychology (1)
- dementia (1)
- depresion (1)
- developmental origins of health and disease (1)
- diabetes mellitus (1)
- diet-induced obesity (1)
- dietary change (1)
- directed acyclic graphs (1)
- early experience (1)
- early-life adversity (1)
- eating behavior (1)
- ecological momentary assessment (1)
- effectiveness (1)
- empathy (1)
- extinction (1)
- family (1)
- fear bradycardia (1)
- fear conditioning (1)
- feature selection (1)
- figural matrices (1)
- food cravings (1)
- gender (1)
- gene expression (1)
- general population (1)
- general population-based cohort (1)
- genome-wide association study (1)
- glomerular filtration rate (1)
- glucose metabolism (1)
- heart rate variability (HRV) (1)
- high fat diet (1)
- host-microbe interactions (1)
- idiographic models (1)
- individualized medicine (1)
- intelligence (1)
- interpersonal problems (1)
- item banking (1)
- large cohort data (1)
- liver inflammation (1)
- longitudinal cohort study (1)
- low-grade inflammation (1)
- measurement error (1)
- mechanisms of change (1)
- mediatation (1)
- medical education & training (1)
- mental illness (1)
- metabolic syndrome (1)
- metabolomics (1)
- miRNS (1)
- mobile health (1)
- multidisciplinary pain treatment (1)
- naturalistic (1)
- neglect (1)
- neurodegeneration (1)
- night shift work (1)
- oral microbiome (1)
- passive sensing (1)
- persistent depressive disorder (1)
- personality disorders (1)
- personality traits (1)
- personalized medicine (1)
- phenotyping (1)
- population-based imaging (1)
- pre-symptomatic Alzheimer’s disease marker (1)
- prediabetes (1)
- prediction modelling (1)
- problem solving (1)
- psychotherapy (1)
- qualitative research (1)
- radiomics (1)
- regional differences (1)
- rs3747742 (1)
- rs56149945 (1)
- sex (1)
- sleep macro-architecture (1)
- slow-wave sleep (1)
- social cognition (1)
- social distance (1)
- startle potentiation (1)
- steroids (1)
- stigma (1)
- systematic review (1)
- test development (1)
- test equating (1)
- time restricted feeding (1)
- time-lagged (1)
- time-restricted feeding (1)
- transcutaneous vagus nerve stimulation (1)
- trauma (1)
- treadmill (1)
- treadmill exercise (1)
- urine normalization (1)
- white matter hyperintensity (1)
- whole-body magnetic resonance imaging (1)
- women’s’ health (1)
- β-klotho (1)
Institute
- Klinik für Psychiatrie und Psychotherapie (50) (remove)
Publisher
- S. Karger AG (16)
- Frontiers Media S.A. (12)
- MDPI (8)
- Springer Nature (3)
- Wiley (2)
- BMJ Publishing Group (1)
- SAGE Publications (1)
Background/Aims: Only a small percentage of pathological gamblers utilizes professional treatment for gambling problems. Little is known about which social and gambling-related factors are associated with treatment utilization. The aim of this study was to look for factors associated with treatment utilization for pathological gambling. Methods: The study followed a sampling design with 3 different recruitment channels, namely (1) a general population-based telephone sample, (2) a gambling location sample and (3) a project telephone hotline. Pathological gambling was diagnosed in a telephone interview. Participants with pathological gambling (n = 395) received an in-depth clinical interview concerning treatment utilization, comorbid psychiatric disorders and social characteristics. Results: Variables associated with treatment were higher age [odds ratio (OR) 1.05, 95% confidence interval (CI) 1.03-1.08], an increased number of DSM-IV criteria for pathological gambling (OR 1.34, 95% CI 1.06-1.70), more adverse consequences from gambling (OR 1.10, 95% CI 1.03-1.16) and more social pressure from significant others (OR 1.17, 95% CI 1.07-1.27). Affective disorders were associated with treatment utilization in the univariate analysis (OR 1.81, 95% CI 1.19-2.73), but multivariate analysis showed that comorbid psychiatric disorders were not independently associated. Conclusion: These results indicate that individuals with more severe gambling problems utilize treatment at an older age when more adverse consequences have occurred. Further research should focus on proactive early interventions.
The early-life microbiome (ELM) interacts with the psychosocial environment, in particular during early-life adversity (ELA), defining life-long health trajectories. The ELM also plays a significant role in the maturation of the immune system. We hypothesised that, in this context, the resilience of the oral microbiomes, despite being composed of diverse and distinct communities, allows them to retain an imprint of the early environment. Using 16S amplicon sequencing on the EpiPath cohort, we demonstrate that ELA leaves an imprint on both the salivary and buccal oral microbiome 24 years after exposure to adversity. Furthermore, the changes in both communities were associated with increased activation, maturation, and senescence of both innate and adaptive immune cells, although the interaction was partly dependent on prior herpesviridae exposure and current smoking. Our data suggest the presence of multiple links between ELA, Immunosenescence, and cytotoxicity that occur through long-term changes in the microbiome.
Being the victim of traumatizing events has consequences that can lead to wellknown mental disorders, such as depression. However, newest studies show that these events do not only affect the victims’ behavior, but also the expression levels of specific genes in their blood and in their brain. Latest research discovered little pieces of RNA in the cells that were long thought to be genetic junk. Nevertheless, these so-called miRNAs can regulate the expression of multiple genes, thus modulating metabolism and cell functioning. The aim of this study was to see if childhood traumatization led to a set of differentially expressed miRNA profiles in the peripheral blood. For this, we used subjects from the SHIP trend cohort, who had previously answered various questionnaires, among them the Childhood Trauma Questionnaire and the Patients Health Questionnaire-9 and analyzed the miRNAs in their blood to find out whether there was an association between the score and the dysregulation of certain miRNAs. Furthermore, we selected 5 different independent variables: PHQ-trend, CTQ score, as well as its subscales Abuse and Neglect, and Major Depressive Disorder lifetime prevalence. The analyses showed a set of up- or downregulated miRNAs in the blood. In a second step, we tried to replicate our results comparing them to results in the literature. Some of the significantly dysregulated miRNAs had previously been described as key players in the pathogenesis of MDD, a few even displaying similar results to ours. The next step was to see if the significant miRNAs had common target genes and if these had been described in the literature as having an influence on MDD, showing positive results. One last step was to see if there were also common biological pathways that were modulated by the differentially expressed miRNA. This analysis did not show promising results since there were almost no brain pathways among the results. For future studies, it will be necessary to validate our results using a clinical sample, such as GANI_MED, where the prevalence of childhood traumatization, as well as MDD, is much higher. By doing this, new possibilities of trauma treatment through modulation of epigenetic pathways could arise. If childhood traumatization leads to a set of dysregulated miRNAs that can end in a positive diagnosis of MDD in adulthood, what effects could have a targeted miRNA therapy on the pathogenesis of these psychiatric disorders?
Abstract
Purpose
Depressive disorders in children and adolescents have an enormous impact on their general quality of life. There is a clear need to effectively treat depression in this age group. Effects of psychotherapy can be enhanced by involving caregivers. In our systematic review and meta‐analysis, we examine for the first time the effects of caregiver involvement in depression‐specific interventions for children and adolescents.
Methods
We included randomized controlled trials examining the effects of interventions for children and adolescents with depression involving their caregivers or families compared to interventions without including caregivers. Primary outcome was the severity of childhood and adolescent depression.
Results
Overall, 19 randomized controlled trials could be included (N = 1553) that were highly heterogeneous regarding outcome measures or the extent of caregiver integration. We were able to include k = 17 studies in our meta‐analysis and find a small but significant effect for family‐involved interventions against active control conditions without family‐involvement at post intervention (α = 0.05, d = 0.34; [0.07; 0.60]; p = .01).
Conclusions
We detected an overall significant but small effect of family/caregivers’ involvement compared to control groups without it. Structured, guideline‐based research is urgently needed to identify for which children/adolescents with depression, under what circumstances, and in what form the family should be effectively involved in their psychotherapy.
Tourette syndrome has been associated with impairments of performance monitoring and alterations of attentional and executive functions. This impairment has been linked to fronto-striatal dysfunctions, which comprise the same braincircuits that are actively engaged in the suppression of tics. We compared behavioral performance and performance monitoring in nineteen boys with Tourette syndrome (TS) (mean age 12.64 years, ± 2.05) and nineteen age-matched controls (mean age 13.16 years, ± 2.29) in a Go/NoGo paradigm. This paradigm was designed to test for problems with inhibition and attention when withholding the response to NoGo targets following repetitive Go targets. The results indicated similar performance accuracy in the TS group and the control group. TS participants showed the expected pattern of Post-Error Slowing, but responded significantly also slower to correct Go trials than the controls. The reaction times (RT) to NoGo targets in commission errors, however, did not differ between the groups. The results suggest that boys with TS develop inhibitory adaptive strategies (overall slower reaction times) to maintain high performance accuracy. These effects may be suspended prior to and during NoGo commission errors.
Patient-reported outcomes (PROs) refer to any report coming directly from patients about how they function or feel in relation to a health condition or its therapy. PROs have been applied in medicine for the assessment of the impact of clinical phenomena. Self-report scales and procedures for assessing physical pain in adults have been developed and used in clinical trials. However, insufficient attention has been dedicated to the assessment of mental pain. The aim of this paper is to outline the implications that assessment of mental pain may entail in psychiatry and medicine, with particular reference to a clinimetric index. A simple 10-item self-rating questionnaire, the Mental Pain Questionnaire (MPQ), encompasses the specific clinical features of mental pain and shows good clinimetric properties (i.e., sensitivity, discriminant and incremental validity). The preliminary data suggest that the MPQ may qualify as a PRO measure to be included in clinical trials. Assessment of mental pain may have important clinical implications in intervention research, both in psychopharmacology and psychotherapy. The transdiagnostic features of mental pain are supported by its association with a number of psychiatric disorders, such as depression, anxiety, eating disorders, as well as borderline personality disorder. Further, addressing mental pain may be an important pathway to prevent and diminish the opioid epidemic. The data summarized here indicate that mental pain can be incorporated into current psychiatric assessment and included as a PRO measure in treatment outcome studies.
Despite effective treatment approaches within the cognitive behavioral framework general treatment effects for chronic pain are rather small to very small. Translation from efficacy trials to naturalistic settings is questionable. There is an urgent need to improve the effectiveness of well-established treatments, such as cognitive-behavior therapy (CBT) and the investigation of mechanisms of change is a promising opportunity. We performed secondary data analysis from routine data of 1,440 chronic pain patients. Patients received CBT in a multidisciplinary setting in two inpatient clinics. Effect sizes and reliable change indices were computed for pain-related disability and depression. The associations between changes in the use of different pain coping skills (cognitive restructuring, activity despite pain, relaxation techniques and mental distraction) and changes in clinical outcomes were analyzed in structural equation models. Pre–post effect sizes range from g = 0.47 (disability) to g = 0.89 (depression). Changes in the use of cognitive restructuring, relaxation and to a lesser degree mental distraction were associated with changes in disability and depression. Effects from randomized trials can be translated to naturalistic settings. The results complement experimental research on mechanisms of change in the treatment of chronic pain and indicate an important role of cognitive change and relaxation as mechanisms of change. Our findings cautiously suggest that clinicians should optimize these processes in chronic pain patients to reduce their physical and emotional disability.
Introduction: It has been shown that Alzheimer’s disease (AD) is accompanied by marked structural brain changes that can be detected several years before clinical diagnosis via structural magnetic resonance (MR) imaging. In this study, we developed a structural MR-based biomarker for in vivo detection of AD using a supervised machine learning approach. Based on an individual’s pattern of brain atrophy a continuous AD score is assigned which measures the similarity with brain atrophy patterns seen in clinical cases of AD.
Methods: The underlying statistical model was trained with MR scans of patients and healthy controls from the Alzheimer’s Disease Neuroimaging Initiative (ADNI-1 screening). Validation was performed within ADNI-1 and in an independent patient sample from the Open Access Series of Imaging Studies (OASIS-1). In addition, our analyses included data from a large general population sample of the Study of Health in Pomerania (SHIP-Trend).
Results: Based on the proposed AD score we were able to differentiate patients from healthy controls in ADNI-1 and OASIS-1 with an accuracy of 89% (AUC = 95%) and 87% (AUC = 93%), respectively. Moreover, we found the AD score to be significantly associated with cognitive functioning as assessed by the Mini-Mental State Examination in the OASIS-1 sample after correcting for diagnosis, age, sex, age·sex, and total intracranial volume (Cohen’s f2 = 0.13). Additional analyses showed that the prediction accuracy of AD status based on both the AD score and the MMSE score is significantly higher than when using just one of them. In SHIP-Trend we found the AD score to be weakly but significantly associated with a test of verbal memory consisting of an immediate and a delayed word list recall (again after correcting for age, sex, age·sex, and total intracranial volume, Cohen’s f2 = 0.009). This association was mainly driven by the immediate recall performance.
Discussion: In summary, our proposed biomarker well differentiated between patients and healthy controls in an independent test sample. It was associated with measures of cognitive functioning both in a patient sample and a general population sample. Our approach might be useful for defining robust MR-based biomarkers for other neurodegenerative diseases, too.
Background: Depression and obesity are widespread and closely linked. Brain-derived neurotrophic factor (BDNF) and vitamin D are both assumed to be associated with depression and obesity. Little is known about the interplay between vitamin D and BDNF. We explored the putative associations and interactions between serum BDNF and vitamin D levels with depressive symptoms and abdominal obesity in a large population-based cohort. Methods: Data were obtained from the population-based Study of Health in Pomerania (SHIP)-Trend (n = 3,926). The associations of serum BDNF and vitamin D levels with depressive symptoms (measured using the Patient Health Questionnaire) were assessed with binary and multinomial logistic regression models. The associations of serum BDNF and vitamin D levels with obesity (measured by the waist-to-hip ratio [WHR]) were assessed with binary logistic and linear regression models with restricted cubic splines. Results: Logistic regression models revealed inverse associations of vitamin D with depression (OR = 0.966; 95% CI 0.951–0.981) and obesity (OR = 0.976; 95% CI 0.967–0.985). No linear association of serum BDNF with depression or obesity was found. However, linear regression models revealed a U-shaped association of BDNF with WHR (p < 0.001). Conclusion: Vitamin D was inversely associated with depression and obesity. BDNF was associated with abdominal obesity, but not with depression. At the population level, our results support the relevant roles of vitamin D and BDNF in mental and physical health-related outcomes.